TrialAnnals of the rheumatic diseases2021

Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials.

Philip J Mease et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.